Canadian pot company Aphria is well positioned in the medical and recreational sectors. It has eyes on Europe but the coronavirus has stalled legalization efforts in the U.S.
Cannabis stocks have disappointed but the coronavirus lockdown might boost consumer demand.
That last year was a terrible one for marijuana stocks is indisputable. So far, 2020 has not been much kinder, with Tilray shares down by more than 50% year to date. Yet,…
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Here's a look at what has caused Canada's marijuana sales to increase so slowly, what impact that had on Aphria in particular, and how the pandemic will affect that company's future.
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
In pandemic times, solid balance sheets have been a beacon of hope to investors, and for those wishing to get into the cannabis industry, a cash-rich company like Aphria may be that…
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Something is moving Tilray stock far higher than other pot stocks. What can account for a 67% one-day jump in the cannabis company's share price?
For an industry that has been crushed since it entered the market, investors have to wonder if the pain is almost over for the cannabis stocks. Aphria may hold some answers.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in…
Although weed stocks have been getting crushed for a long time now, investors historically have made a lot of money bottom-fishing and value investing. Is Aurora Cannabis the place to be now?
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
